HD, a healthcare and surgery marketplace based in Thailand, has announced the completion of a Series A-1 strategic extension round, raising its total Series A funding to USD 7.8 million. The extension includes participation from Merck Sharp & Dohme (MSD), a healthcare company based in the United States. This additional support will enable HD to expand its impact, aiming to make affordable and accessible healthcare available across Southeast Asia.
By the end of 2025, HD plans to support over 5,000 healthcare providers and reach 600,000 patients through its platforms, HDmall and Jib AI, which help healthcare providers focus on patient care. The funding marks MSD IDEA Studio Asia Pacific’s first investment in Southeast Asia, as part of MSD Global Health Innovation Fund’s commitment to supporting early-stage companies in transformative healthcare solutions.
Since its initial Series A round, HD has experienced substantial growth, developing and deploying Jib AI technology. This AI system currently manages more than 60% of HD’s chat commerce, providing 24/7 automated customer support. The technology allows healthcare professionals to focus more on patient care by handling initial triaging and care navigation.
In the coming year, Jib AI will expand its capabilities to include tasks such as order processing, scheduling, electronic health record management, and AI-enabled virtual care. HD’s platform has already facilitated healthcare access for over 400,000 patients and continues to evolve to meet the needs of healthcare providers in the digital era.
(Source: TechNode Global)
